In one paragraphArticle in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
M Nieves ArandaInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València, Valencia, Spain.ORCID 0000-0002-1392-3539 Isabel CaballosInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València, Valencia, Spain.ORCID 0000-0001-6334-380X Alba López-PalaciosInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València, Valencia, Spain.ORCID 0000-0002-4397-277X Héctor Carmona-SalidoInstituto Universitario de Biotecnología y Biomedicina (BIOTECMED), Universitat de València, Burjassot, Valencia, Spain.ORCID 0000-0003-3799-0688 Eva SanjuanInstituto Universitario de Biotecnología y Biomedicina (BIOTECMED), Universitat de València, Burjassot, Valencia, Spain.ORCID 0000-0001-7671-0779 Elena AznarInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València, Valencia, Spain.ORCID 0000-0003-0361-3876 Carmen AmaroInstituto Universitario de Biotecnología y Biomedicina (BIOTECMED), Universitat de València, Burjassot, Valencia, Spain.ORCID 0000-0003-1323-6330 Ramón Martínez-MáñezInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València, Valencia, Spain.ORCID 0000-0001-5873-9674 Andy Hernández-MontotoInstituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València, Valencia, Spain.ORCID 0000-0001-5623-9836 Funding
Generalitat Valenciana (Spain) CIAICO/2021/293Generalitat Valenciana (Spain) CIAICO/2024/236Instituto de Salud Carlos III CIBER-ConsorcioCentrodeInvestigaciónBiomédicaenRed(CB06/01/2012)Ministerio de Ciencia, Innovación y Universidades (MICIU) and the Agencia Estatal de Investigación (AEI/10.13039/501100011033), with co-funding from the European Regional Development Fund (ERDF), European Union PID2020-120619RB-I00Ministerio de Ciencia, Innovación y Universidades (MICIU) and the Agencia Estatal de Investigación (AEI/10.13039/501100011033), with co-funding from the European Regional Development Fund (ERDF), European Union PID2021-126304OB-C41Ministerio de Ciencia, Innovación y Universidades (MICIU) and the Agencia Estatal de Investigación (AEI/10.13039/501100011033), with co-funding from the European Regional Development Fund (ERDF), European Union PID2024-155683OB-C41Ministerio de Ciencia, Innovación y Universidades (MICIU) and the Agencia Estatal de Investigación (AEI/10.13039/501100011033), with co-funding from the European Regional Development Fund (ERDF), European Union PID2024-162627OB-I00Spanish Ministry of Science and Innovation (MCIN) with funding from the European Union European Union NextGenerationEU (PRTR-C17.I1) and the Generalitat Valenciana (GVA-THINKINAZUL/2021/027; Principal Investigators: Carmen Amaro and B. Fouz, Universitat de València)
6 · The paper itselfAbstract
Vibrio vulnificus, a marine pathogen and climate change biomarker, poses serious risks to human and animal health through seafood consumption and seawater exposure. Rapid detection methods are urgently needed for both vibriosis diagnosis and surveillance in warming coastal waters. We report a fluorogenic biosensor based on nanoporous anodic alumina loaded with rhodamine B and capped with an oligonucleotide probe targeting a unique sequence of the vvhA cytolysin gene, specific to V. vulnificus. In the presence of the target DNA, the probe is displaced, pores open, and the fluorophore is released, generating a measurable signal. The biosensor exhibited high sensitivity and selectivity across diverse matrices, including fish mucus and serum, human serum, sterilized brackish water, and-critically-unprocessed natural lake and seawater samples, without DNA extraction or amplification. Detection limits ranged between 10² and 5 × 10² CFU mL⁻¹, comparable in sensitivity to state-of-the-art qPCR assays. The biosensor outperformed conventional approaches in speed, simplicity, and cost-effectiveness, while maintaining accuracy. These findings underscore the potential of this platform for integrated One Health applications, bridging environmental monitoring with rapid diagnosis of vibriosis in humans and animals. Preliminary results from this study were previously made available as a preprint in SSRN (DOI: https://ssrn.com/abstract=5032822).
Indexed as
Biosensing TechniquesVibrio InfectionsVibrio vulnificusAnimalsBacterial ProteinsBiomarkersClimate ChangeFluorescent DyesHumansRhodaminesSensitivity and SpecificityBacterial ProteinsBiomarkersFluorescent Dyesrhodamine BRhodaminesVvhA protein, Vibrio vulnificusclimate changehuman healthmolecular gatesnanoporous anodic aluminaoligonucleotideoptical sensorsVibrio vulnificus
Identifiers
PMID42013233
PMCPMC13098796
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390